GAVI Alliance Partners' Forum: Introduction of Pneumococcal Vaccine in Rwanda

Published Online: Saturday, January 28, 2012
Follow Pharmacy_Times:
GAVI, the Global Alliance for Vaccines and Immunisation, is a nonprofit alliance that seeks to advance global public health by fighting declining rates of vaccination worldwide, and particularly in the world's poorest countries. In developing countries, such as Rwanda, the availablility of pneumococcal vaccination represents a major step toward improving public health.

Related Articles
A reduction in pediatric health care visits related to otitis media between 2001 and 2011 appears to be due to uptake of the pneumococcal conjugate vaccine, according to the results of a new study.
A new study finds that decreased rates of infection with serotypes of pneumococcal disease the PCV7 vaccine protects against outweigh increased rates of infection with serotypes it does not protect against.
Streptococcus pneumoniae is the leading cause of life-threatening illness globally.
A decade after the 7-valent pneumococcal conjugate vaccine was introduced, it led to approximately 168,000 fewer annual hospitalizations for pneumonia.
Latest Issues
$auto_registration$